학술논문

NS-187, a potent and selective dual Bcr-Abl/Lyn tyrosine kinase inhibitor, is a novel agent for imatinib-resistant leukemia
Document Type
Journal
Source
BLOOD; DEC 1 2005, 106 12, p3948-p3954, 7p.
Subject
Language
English
ISSN
00064971